What is neuroethics and how it has evolved to make brain research and neurotechnology ethical in both medical and non-medical applications. In the latest episode of NeuroCentury, Paweł Świeboda explores these questions with Dr Arleen Salles, Founding Board Member of the Institute of Neuroethics in Atlanta, Georgia and Director of Neuroética in Buenos Aires, Argentina. Arleen co-led the work on Responsible Research and Innovation in the Human Brain Project (2014-2023) and serves as an Executive Board Member of the International Neuroethics Society.
Paweł and Arleen discuss methods of integrating ethical and social considerations into neuroscience and neurotechnology projects: why are the questions about autonomy, integrity, agency or identity so important and how they should be addressed in the research and innovation process early on. The conversation considers whether self-regulation can successfully lead companies to incorporate ethics into their business models. Paweł and Arleen also explore the meaning of consent, one of the basic principles in biomedical ethics, in neuro-related research. Their discussion raises the question whether the debate over responsible AI design, development and deployment should be conducted jointly with the one on social and ethical considerations in neurotechnology.
In addition, the conversation is about international efforts on responsible innovation in neurotechnology, starting with the OECD Recommendation in 2019, the work of UN bodies, and more recently, the European Union. It also considers what role cultural considerations need to play in the debate over neurotechnology governance.
#neurocentury #neuroethics #neurotechnology #brain
_______________
Music for the NeuroCentury podcast is composed by Rafał Kulczycki
